Upton, Emily; Doogan, Catherine; Fleming, Victoria; Leyton, Pedro Quijada; Barbera, David; Zeidman, Peter; Hope, Tom; Latham, William; Coley-Fisher, Henry; Price, Cathy; Crinion, Jennifer and Leff, Alex. 2024. Efficacy of a gamified digital therapy for speech production in people with chronic aphasia (iTalkBetter): behavioural and imaging outcomes of a phase II item-randomised clinical trial. eClinicalMedicine, 70, 102483. ISSN 2589-5370 [Article]

Preview

Text PIIS2589537024000622.pdf - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview

Abstract or Description

Background
Aphasia is among the most debilitating of symptoms affecting stroke survivors. Speech and language therapy (SLT) is effective, but many hours of practice are required to make clinically meaningful gains. One solution to this ‘dosage’ problem is to automate therapeutic approaches via self-supporting apps so people with aphasia (PWA) can amass practice as it suits them. However, response to therapy is variable and no clinical trial has yet identified the key brain regions required to engage with word-retrieval therapy.

Methods
Between Sep 7, 2020 and Mar 1, 2022 at University College London in the UK, we carried out a phase II, item-randomised clinical trial in 27 PWA using a novel, self-led app, ‘iTalkBetter’, which utilises confrontation naming therapy. Unlike previously reported apps, it has a real-time utterance verification system that drives its adaptive therapy algorithm. Therapy items were individually randomised to provide balanced lists of ‘trained’ and ‘untrained’ items matched on key psycholinguistic variables and baseline performance. PWA practised with iTalkBetter over a 6-week therapy block. Structural and functional MRI data were collected to identify therapy-related changes in brain states. A repeated-measures design was employed. The trial was registered at ClinicalTrials.gov (NCT04566081).

Findings
iTalkBetter significantly improved naming ability by 13% for trained items compared with no change for untrained items, an average increase of 29 words (SD = 26) per person; beneficial effects persisted at three months. PWA’s propositional speech also significantly improved. iTalkBetter use was associated with brain volume increases in right auditory and left anterior prefrontal cortices. Task-based fMRI identified dose-related activity in the right temporoparietal junction.

Interpretation
Our findings suggested that iTalkBetter significantly improves PWAs’ naming ability on trained items. The effect size is similar to a previous RCT of computerised therapy, but this is the first study to show transfer to a naturalistic speaking task. iTalkBetter usage and dose caused observable changes in brain structure and function to key parts of the surviving language perception, production and control networks. iTalkBetter is being rolled-out as an app for all PWA and anomia: https://www.ucl.ac.uk/icn/research/research-groups/neurotherapeutics/projects/digital-interventions-neuro-rehabilitation-0 so that they can increase their dosage of practice-based SLT.

Item Type:	Article
Identification Number (DOI):	https://doi.org/10.1016/j.eclinm.2024.102483
Additional Information:	Funding: National Institute for Health and Care Research, Wellcome Centre for Human Neuroimaging.
Data Access Statement:	Anonymised data will be made available for reasonable requests to APL with scientific rational and sound methodology
Keywords:	Aphasia, Speech production, Computerised therapy, Structural MRI, Functional MRI Randomised controlled trial
Departments, Centres and Research Units:	Computing
Dates:	Date Event 26 January 2024 Accepted 21 February 2024 Published
Item ID:	36336
Date Deposited:	14 May 2024 14:31
Last Modified:	14 May 2024 14:35
Peer Reviewed:	Yes, this version has been peer-reviewed.
URI:	https://research.gold.ac.uk/id/eprint/36336

View statistics for this item...

Edit Record (login required)